Application Nr Approved Date Route Status External Links
NDA022264 None Intramuscular None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Invega Sustenna ® (Paliperidone Palmitate) Is Indicated For The Treatment Of: Schizophrenia In Adults [See Clinical Studies (14.1) ]. Schizoaffective Disorder In Adults As Monotherapy And As An Adjunct To Mood Stabilizers Or Antidepressants [See Clinical Studies (14.2) ]. Invega Sustenna ® Is An Atypical Antipsychotic Indicated For Treatment Of Schizophrenia In Adults. ( 1 ) Treatment Of Schizoaffective Disorder In Adults As Monotherapy And As An Adjunct To Mood Stabilizers Or Antidepressants. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Paliperidone Palmitate PALIPERIDONE PALMITATE ZINC1481956

Comments